Cannon, P.J.Heinemann, H. O., Stason, W.B. and Laragh, J.H.: Ethacrynic acid: effectiveness and mode of diuretic action in man. Circulation31: 5, 1965.
2.
Coldbeck. J.H. : Experience with alkylating agents in the treatment of children with the nephrotic syndrome. Med. J. Australia2: 987, 1964.
3.
Cooke, R.E., Lange, K., Heymann, W. and Guild, H.: Therapy of nephrotic syndrome. In Proceedings of the 11th Annual Conference on the Nephrotic Syndrome. Edited by J. Metcalf. New York. National Kidney Disease Foundation, 1960, pp. 286-296.
4.
Goodman, H.C. , Wolff, S.M., Carpenter, R.R., Andersen, B.R. and Brandriss , M.W.: Current studies on effect of antixnetabolites in nephrosis, other neo-neoplastic diseases, and experimental animals. Combined Clinical Staff Conference at National Institutes of Health. Ann. Int. Med. 59: 388, 1963.
5.
Harter, J.G. , Reddy, W.J. and Thorn, G.W.: Studies on intermittent corticosteroid dosage regimen. New England J. Med.269: 591, 1963 .
6.
Kelley, V.C. and Panos, J.C.: Nephrotic syndrome in children, 1. Clinical response to nitrogen mustard therapy. J. Pediat.41: 505, 1952.
7.
Lagrue, G. et al.: Resultats de la chimio thérapie prolonge an cours de certains syndromes néphrodques. J. d'UroL70: 156, 1964.
8.
West, C.D.: Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis. Amer. J. Dis. Child.95: 498, 1958.
